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Available online 1 September 2017Background: N94% of new annual leprosy cases are diagnosed in populations co-endemic for soil-transmitted hel-
minths (STH). STH can profoundly dysregulate host immune responses towards Th2 bias, which can be restored
over time after deworming.Wehypothesize that STH co-infection is associatedwith leprosy reaction (denoted as
simply “reaction” herein) occurrence within a co-endemic population.
Methods: A cohort study was performed on a cohort of Nepalese leprosy patients across treatment and diagnostic
classificationswhowere screened by routine fecal smearmicroscopy andmultiplex quantitative PCR (qPCR) for As-
caris lumbricoides (Al), Strongyloides stercoralis (Ss), Ancyclostoma duodenale (Ad) and Necator americanus (Na).
Results:Among 145 patients, 55%were positive for ≥1 STH (STH+): 34%Al+, 18% Ss+, 17%Ad+and 5%Na+. Sig-
nificant inverse STH and reaction relationships were evidenced by the bulk of cases: 63% reaction-negative were
STH+ of total cases (p = 0.030) while 65% reaction-positive were STH− in new cases (96; p = 0.023). Strikingly,
the majority of STH+ were reaction-negative, even when considering each species: 59% Al+, 60% Ss+, 62% Ad
+ and 67% Na + of new leprosy cases.
Conclusions: Absence of STH co-infection is associated with leprosy reaction at diagnosis within a co-endemic pop-
ulation. This is likely due to immune reconstitution effects after deworming or interruptionof chronic STH-mediated
immune dysregulation.agge@leprosymissio








Over 94% of annual new leprosy cases originate from areas co-en-
demic for soil-transmitted helminths (STH), including all 16 countries
reporting N1000 new cases annually (Fig. 1) (WHO, 2012; WHO,
2015). A growing body of evidence demonstrates that chronic STH in-
fections wield profound systemic immune dysregulation towards a
Th2 bias, proven relevant in chronic immunopathologies such as
human immunodeficiency virus (HIV), tuberculosis (TB), malaria and
allergy (Salgame et al., 2013; Coakley et al., 2016). Leprosy can present
across the Th1–Th2 immunological spectrum, respectively classified as
polar tuberculoid (TT) or polar lepromatous (LL) leprosy with border-
line classifications between: borderline tuberculoid (BT), borderline
borderline (BB) and borderline lepromatous (BL) leprosy (Scollard et
al., 2006a). Chronic STH co-infections have been associated withn.org
der the CC BY-NCmultibacillary (MB) as compared to paucibacillary (PB) leprosy, de-
creased Th1 and increased Th2 cytokines and likely facilitationM. leprae
growth and disease progression (Diniz et al., 2010). Other STH co-infec-
tion immunopathologies have shown that antihelminthic treatment
(deworming) can permit immune reconstitution over ≥2–22 months
likely depending on complex factors including complicit disease and
(mal)nutrition as well as STH variables such as species, combination,
burden and duration of infection (van den Biggelaar et al., 2004; Elias
et al., 2008; Ivan et al., 2015).
The most damaging physical consequence of leprosy is permanent
disability, primarily caused by neuropathy induced during dynamic and
unpredictable Th1/Th2 complications called leprosy reactions (denoted
as simply “reaction” herein) (Khadge et al., 2015; Corstjens et al., 2016).
Due to persistentMycobacterial leprae antigen, Reactions can variably per-
severe as amajor clinical concern affecting up to 30–50%of patients either
before, during or even years after multi-drug therapy (MDT) (Scollard et
al., 2006a). Increased Th1 responses correlatewith Type 1 Reaction (T1R),
while patients with more dominant Th2 response histories (BL-LL) may
develop a Type 2 Reaction (T2R) also known as Erythema Nodosum-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Global map of reported STH and leprosy. STH and leprosy exist primarily within populations living with significant and sustained sanitation, housing and poverty issues. While the
WorldHealth Organization posts regular bulletins, individually updated data is not always submitted; therefore, themost recent reported data from 2009 to 2015 is shown for each nation
(WHO, 2012;WHO, 2015; Pullan et al., 2014;WHO, 2009). Red indicates STH and leprosy are both reported. Green indicates STH reported but leprosy data unreported or unavailable. Blue
indicates STH reported but no leprosy cases reported. Gray indicates no endemic STH with few leprosy cases reported. White indicates neither leprosy nor STH are endemic.
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stitution inflammatory syndrome (IRIS) after prolonged immunosup-
pression have been associated with reaction, including HIV highly active
antiretroviral therapy (HAART) or cessation of extended TNF-α intercep-
tor therapy (Scollard et al., 2006b; Deps & Lockwood, 2008). Therefore, it
is reasonable that immune reconstitution after removal or interruption of
chronic STH co-infection could be a previously unsuspected yet indige-
nous trigger for reaction development.
We hypothesized that STH co-infection status is associated with the
occurrence of reaction. In this observational cohort study, we employed
routine microscopy and multiplex quantitative real time PCR (qPCR) to
screen 145 Nepalese leprosy patients for endemic STH. Results indicate
that reaction status is significantly and inversely associated with STH.
2. Materials and Methods
Fecal samples alongside clinical information were collected from
145 Nepalese leprosy patients collected by convenience sampling as
they attended Anandaban Hospital (Lalitpur) or satellite clinics (Patan,Table 1
Primer sequences for target soil-transmitted helminths (Basuni et al., 2011).
Target organism Oligo name Oligonucleotide sequence
Ascaris lumbricoides Al-F 5′-GTA ATA GCA GTC GGC GGT TTC T
Al-R 5′-GCC CAA CAT GCC ACC TAT TC-3′
Al-P ROX-5′-TTG GCG GAC AAT TGC ATG C
Strongyloides stercoralis Ss-F 5′-GAA TTC CAA GTA AAC GTA AGT C
Ss-R 5′-TGC CTC TGG ATA TTG CTC AGT TC
Ss-P Alexa 680–5′-ACA CAC CGG CCG TCG
Ancylostoma duodenale Ad-F 5′-GAA TGA CAG CAA ACT CGT TGT T
Ad-R 5′-ATA CTA GCC ACT GCC GAA ACG T
Ad-P (MGB probe) JOE-5′-ATC GTT TAC CGA CTT TAG-3′
Necator americanus Na-F 5′-CTG TTT GTC GAA CGG TAC TTG C-
Na-R 5′-ATA ACA GCG TGC ACA TGT TGC-3
Na-P (MGB probe) FAM-5′-CTG TAC GCA TTG TAT AC-3′
Phocine Herpes PhHV-F 5′-GGG CGA ATC ACA GAT TGA ATC-3
PhHV-R 5′-GCG GTT CCA AAC GTA CCA A-3’
PhHV-P Cy5–5′-TTT TTA TGT GTC CGC CAC CAButwal and Chandranigahapur) from December 2011 to September
2013. Participants included: newly diagnosed, undergoing MDT, new
reaction, relapse or defaulter at MDT restart and released from treat-
ment (RFT) after completion of MDT. Comprehensive leprosy diagnosis
included clinical and physiotherapist evaluations, slit skin smear bacte-
rial index (BI) and skin biopsy histopathology. Signed informed ethical
consent, participant chart review and data collection with case report
forms were performed under approval by the Nepal Health Research
Council (NHRC, Approval 101/2011), which conforms to the standards
indicated by the Declaration of Helsinki. Patients refusing consent,
aged under 18 or above 60 years, with chronic disease, pregnant or lac-
tating were excluded from the study.
Wet mount fecal smear microscopy was performed by a qualified
medical technologist. Remaining stool was stored at −80 °C until pro-
cessing. DNA isolation andmultiplex qPCRwas performed as previously
described for detection of Ascaris lumbricoides (Al, roundworm),
Strongyloides stercoralis (Ss, threadworm), and hookwormsAncylostoma
duodenale (Ad), Necator americanus (Na) (Basuni et al., 2011). Primer
sequences for multiplex qPCR are listed in Table 1. Briefly, 100 mgSize of the target region Target gene
T-3′ 89 bp ITS1
GA T-3′ -black hole quencher 2
AT TAG C-3′ 101 bp 18 s
-3′
CTG C-3′ -black hole quencher 3








T CTG GAT C-3′-black hole quencher 2
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buffer and heated for 10min at 100 °C. Then, the stoolwas processed ac-
cording to the manufacturer's protocol (QIAamp DNA Minikit, Qiagen,
Catalog No. 51306). Phocine herpesvirus 1 (PhHV-1) for an internal
DNA extraction control was kindly donated by Dr. Martin Schutten (De-
partment of Virology, Erasmus MC, Netherlands) and was added at the
AL buffer stage. STH species-specific plasmid-positive controls were do-
nated by Dr. RahmahNoordin (Institute for Research inMolecularMed-
icine (INFORMM), Universiti Sains Malaysia) which were previously
reported with lower detection limits of 10 copies for Al, Ad and Ss and
1000 copies for Na (Basuni et al., 2011). Analyses were performed
with Qiagen Multiplex PCR kits in a Rotor Gene Q series machine with
Ver.2.1.0 software (Qiagen, Germany). STH burden was assigned
based on cycle threshold values as previously described: high (≤30),
moderate (N30 ≤ 35), low (N35) (Arndt et al., 2013).
2.1. Statistical Methods
Data were analyzed with the use of SPSS (version 12, SPSS Inc., Chi-
cago, IL) and STATA9 (Stata Corporation, TX). The statistical significance
of associations between groups were assessed primarily using the chi-
squared test. Logistic regression was used to assess helminth positivity
as a predictor of reaction outcomes.
3. Results
Among 145 total patients (Fig. 2a), comprehensive diagnosis indi-
cated 21% PB and 79% MB cases across the Ridley-Jopling spectrum: 5
pure neuritic (PN, 3%), 6 TT (4%), 71 BT (49%), 1 BB (1%), 29 BL (20%),
33 LL (23%). Fifty-seven percent (82/145) were in reaction-positive:
49 T1R (34%), 13 ENL (9%), and 20 neuritis (14%). The majority were
newly diagnosed (96, 66%) alongside 32 undergoing MDT (25%, range
2 weeks to 12 months), 14 relapse or restart after default (7%) and 3
RFT (2%, range 1–36 months).
Within limited resource contexts, documented medical history for
new or referral cases is usually limited or nonexistent. Therefore, partic-
ipants were asked to self-report history of deworming. Most patients
(112/145, 77%) indicated none or unknown within the last year (Fig.
2b). However, 23 remembered deworming within ≤6 months, 57%
(13) were reaction-positive (11 MB, all BT-LL). Interestingly, out of the
10 patients who reported deworming within ≤3 months: 8 patients
(80%) were reaction-positive (4 T1R, 3 ENL, 1 neuritis only).
Of 145 total patients, only 6 (4%) cases evidenced parasites by wet
mount fecal smear microscopy: 3 (2%) for STH and 3 (2%) for Giardia
and/or Entamoeba histolytica (Fig. 3a). Molecular testing by qPCR, howev-
er, identified 79/145 (55%) positive for ≥1 STH (STH+): 34% Al + (49),
18% Ss+ (26), 17% Ad+ (25) and 5% Na+ (7). All microscopy STH+pa-
tients were also STH+ by qPCR. Most STH+ (56/79; 71%) were single
species infections with multiple STH infections (polySTH+) evidencedFig. 2.Demographics for 145 Nepalese leprosy patients screened for soil-transmitted helminths
reported overall for patients attending Anandaban services (data not shown) including sex, bac
Ridley-Jopling classification (7% were perineural or tuberculoid (TT); BT = borderline tuberc
neuritis, T1R = Type 1 reaction, ENL = erythema nodosum leprosum). b) Most participants
previous year. However, of those who did self-report deworming within the previous 3–6 monin 18 (23%), 4 (5%) and 1 (1%) with 2–4 STH species respectively. Across
individual STH, Ct values indicated carriage of 18% (19/107) low, 50% (54/
107) moderate and 32% (34/107) high infection burdens. Among new
leprosy cases (96), 47% (45/96) hosted ≥1 STH, with patterns in species
and polyparasitism similar to the total patient cohort.
STH co-infection status did not significantly differ among total pa-
tients in categories of gender, PB/MB, BI positivity or Ridley-Jopling clas-
sification (Fig. 3b). When considering reaction, however, a pattern of
inverse presence became apparent (Fig. 3b). STH− cases were signifi-
cantly more likely to be reaction, with STH+ significantly more likely
to be reaction-negative (p= 0.030; OR 2.09, CI 1.07–4.08).When divid-
ed into reaction types, group numbers reduced and statistical signifi-
cance was lost. Ongoing MDT (32) patients were mostly reaction-
positive (21), 52% (11/21) of which were STH−; while reaction-nega-
tive (10)were 83% STH+(10/12). Out of 17RFT/Defaulter/RFT patients,
64% (11) were reaction-positive and 94% (16) were STH−.
Among new leprosy cases (n = 96) (Fig. 4a), inverse STH/reaction
trends were significant with the majority of reaction-negative (56/96;
58%) also STH+ (p=0.023; OR 2.59, CI 1.13–5.92). Conversely, thema-
jority of reaction-positive (62/96; 65%)were STH− (comparisonwithin
reaction cases: p = 0.037; OR 2.06, CI 1.04–4.10). Among new LL pa-
tients (21), 8 of 9 reaction-positive were STH−/LL (89%) (5 neuritis, 1
T1R, 2 ENL); conversely, 8 of 9 (89%) STH+/LL were reaction-negative
(Fig. 4b). STH− cases were primarily reaction-positive: 65% of total
(43/66) and 61% (31/51) of new leprosy cases. When considering indi-
vidual STH species (Fig. 5), themajority positive was reaction-negative:
59% Al + (16/27), 60% Ss + (9/14), 62% Ad+ (8/13) and 67% Na+ (4/
6) of new leprosy cases. Of polySTH+ (12), 75% (9) presented reaction-
negative. Most STH infection burdens were moderate (Ct values of 30–
35). Most Al + (78%, 21/27) and Ss + (54%, 8/15) were mono-STH in-
fections, while most Ad + (85%, 11/13) and Na + (67%, 4/6) were
polySTH+ (i.e., had ≥1 of the other STH tested). If using an alternate
scale with a narrower definition of high burden (Ct values of b25)
broadeningmoderate burden range (Ct values 25–35) significant differ-
ences evidenced. Moderate Al + cases were significantly reaction-neg-
ative (65%, 13/20) in comparison to STH− cases (p = 0.043). The
majority (82%, 9/11) of moderate Ad + co-infections significantly pre-
sented reaction-negative (p = 0.014) but were also mostly (7/9)
polySTH+.
Corticosteroid treatment for reactions is known to increase suscepti-
bility to Ss infection (De Souza et al., 2014). Among the 145 total pa-
tients, 8 had received corticosteroids prior to sampling: 4 T1R and 4
ENL cases ofwhich 4were STH+.Only one new casewas under cortico-
steroid treatment at sampling (T1R, low burden Al+).
4. Discussion
Our study results demonstrate that STH co-infection is inversely as-
sociated with leprosy reactions within a co-endemic setting; therefore,(STH). a) Leprosy demographicswithin the sampled cohortwere similar to those normally
terial index (BI), WHO leprosy classification of paucibacillary (PB) or multibacillary (MB),
uloid; BL = borderline lepromatous; LL = lepromatous) or leprosy reaction (LR: Neu =
(77%) either could not recall or denied having taken deworming treatment within the
ths, 80–57% developed LR (respectively).
Fig. 3. Direct microscopy and qPCR result for 145 Nepalese patients and STH prevalence by clinical parameters. a) Fecal samples from 145 patients were screened by simple smear
microscopy (first bar) or by quantitative PCR (qPCR) for soil-transmitted helminths (STH) depicted as combined (qPCR+ column) or individually for Ascaris lumbricoides (Al),
Strongyloides stercoralis (Ss), Ancyclostoma duodenale (Ad) and Necator americanus (Na). Samples negative for any STH are clear in color whereas those positive for one or multiple STH
are shaded black or hatched, respectively. b) When compared against common leprosy indicators, STH presence was significantly associated with presence of LR (Neuritis, Type 1
reaction (T1R) and ErythemaNodosumLeprosum) but not associatedwithin gender,WHOclassification (paucibacillary (PB) ormultibacillary (MB)), or slit skin smear bacterial index (BI).
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absence or disturbance of a once chronic and pathologically complicit
STH co-infection. STH infection disturbances can occur in response to
contextual transitions or changes implemented for individuals or popu-
lations, including: immigration, health care access, housing and sanita-
tion improvements, Mass Drug Administration (MDA) or other
unprogrammed deworming events. Effective against Al and hook-
worms, single dose albendazole is one of the most commonly pre-
scribed dewormers. However, prolonged or other treatments are
required for other STH (i.e., 2× daily/7 days for Ss); therefore, non-spe-
cific deworming with single dose albendazole may interrupt but not
eliminate other chronic STH infection (Hu et al., 2013). Since 2003, a
15 year anti-filariasis MDA program began in Nepal, employing a single
dose of diethylcarbamazine partneredwith albendazole in 5 year annu-
al treatment cycles staggered across grouped districts (Go, 2010). Also
beginning in 2003, annual leprosy reaction patient visitswithin our pro-
grams tripled and havemaintained increased levels ever since (data not
shown). While it may be anecdotal, the correlation corresponds with
possible deworming-related IRIS events within a co-endemic
population.
In limited resource contexts, it can be clinically impossible to vali-
date deworming history or accurately differentiate recent, absent,
interrupted, chronic or combined STH infections. Within our study,
most Nepalese (77%, 112/145) self-reported unknown or no exposure
within ≤12 months prior to sampling. Of those who did recall
deworming within ≤3–6 months, the majority (80–57% respectively)Fig. 4. Soil-transmitted helminths (STH) co-infection and leprosy reaction associations in new
inverse relationships between presence and STH and reaction became more evident. a) Th
(STH+); whereas, the significant majority of those with reaction (LR+) were not co-infected
classification: pure neuritic (PN), tuberculoid (TT), borderline tuberculoid (BT), borderline l
reported LR+, while 75% new STH+/LL reported LR−.had presented reaction-positive: neuritis, T1R and ENL. Most, but not
all, were patients who generally carry more M. leprae burden: MB,
BI+, BT-LL. Both T1R and ENL development have been reported out-
comes from pharmacological IRIS (Ramien et al., 2011; Sopirala et al.,
2011). Although deworming can remove the governing force behind
immune dysregulation, multiple cellular mediators (i.e., macrophages,
dendritic cells) commissioned under the previous administration may
actively persist or be retained (T regulatory cells) for variable lengths
of time until repopulation occurs, potentially resulting in defense man-
agement conflicts (Salgame et al., 2013; Steinfelder et al., 2016; Taylor
et al., 2012).
Ourfindingsmark pioneering use of STHmultiplex qPCR among lep-
rosy patients and in Nepal. Similar to other reports (Easton et al., 2016;
Llewellyn et al., 2016), qPCR unveiled similar proportions (i.e., Al N Ad
and Na (hookworms) N Ss) yet higher levels of STH infection (55% pos-
itive) as compared to local microscopy (2% positive) or previous studies
(Pullan et al., 2014; Kunwar et al., 2016).
The fact that 55% of all and 47% of new leprosy cases attending a na-
tional leprosy referral hospital were STH+, even within an era of MDA,
is significant and indicative of the pervasive co-infection background in
whichM. leprae continues to transmit and persist as a disease. Secondly,
STH occurrencewas similar among all cases in regard to common lepro-
sy indicators except reactions, dynamic situations previously associated
with IRIS (Deps & Lockwood, 2008). Inverse STH/reaction relationships
were repeatedly demonstrated across total patient, new case, individual
STH species and polySTH categories. Moderate STH burden was mostleprosy cases. Of the 145 total patients sampled, 96 were new leprosy cases. Significant
e significant majority of those without reaction (LR-) were co-infected with ≥ 1 STH
with STH (STH−). b) STH presence was not significantly associated with Ridley-Jopling
epromatous (BL) and lepromatous (LL) leprosy. Nevertheless, 89% of STH−/LL patients
Fig. 5. Ct values corresponding to respective soil transmitted helminths. Cycle threshold values from multi-plex quantitative PCR (qPCR) were used to group STH infection burdens into
high (Ct b 30),moderate (Mod, Ct N 30 b 35), and low (Ct N 35) (Arndt et al., 2013). STHmono-infections are represented by circles, whereas thosewithin ≥ 1 STH infections (polySTH) are
represented by triangles. Open characters represent LR−, while closed characters represent LR+. Themajority of STH+were mono-infections of moderate to high burden. Regardless of
STH infection burden or whether polySTH, the majority of each STH species positive cases trended LR−.
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ed with reaction-negative. Tools to comprehensively evaluate STH bur-
den remain limited and contextually challenging; therefore, most STH
immune dysregulation has been reported in association with presence
regardless of burden (Salgame et al., 2013; van den Biggelaar et al.,
2004; Elias et al., 2008; Ivan et al., 2015).
While trendswere often evident in themajority, associationwas not
absolute: some were reaction-positive/STH+ or reaction-negative/
STH−. A 10 year Brazilian retrospective chart study of fecal microscopy
reported chronic STH co-infection more often in MB and LL cases: find-
ingswhichwere not replicated in our study (Diniz et al., 2010). This dis-
similarity highlights the transitory qualities involved in STH co-
infection immunedysregulation and reconstitution. Therewere no indi-
cations of deworming history or context reported in the Brazilian co-
hort. Fecal evidence for STH detection, either by microscopy or qPCR,
can rapidly disappear after deworming (Verweij, 2014) whereas, evi-
dence of leprosy pathology or M. leprae residues can persist for years
after effective MDT (Scollard et al., 2006a). Consequently, significant
correlation between leprosy and chronic STH for historical extrapola-
tions can be skewed by deworming activitieswithin a population. Addi-
tionally, those who receive therapeutic deworming without
concomitant infrastructure changes such as sanitation improvements
are at high risk for re-infection within co-endemic settings. A recent
small study reported microscopy STH+ association with ENL (Oktaria
et al., 2016). Confoundingly for comparisons, however, the 8with either
active or historical ENL were grouped (two very different immunologi-
cal states), all of which had received extended corticosteroid treatment
prior to sampling. Nevertheless, in regard to reactions: 75% (8/12) of our
new STH−/LL patients reported reaction-positive, while 89% (1/9) new
STH+/LL reported reaction-negative. Therefore, 76% (16/21) of LL
(most severe leprosy growth) new cases strongly displayed an inverse
STH/reaction status.
Our results provoke a clinical dilemma: candeworming a leprosy pa-
tient from a co-endemic setting precipitate reaction and disabilitydevelopment? As there are no standardized recommendations, leprosy
care providers necessarily but variably practice deworming within co-
endemic settings. Notably, aside from diagnosis coincidence, leprosy re-
actions most often develop during the first 6–12months of MDT: a sea-
son corresponding with likely improved health care access and
deworming-associated immune reconstitution durations (Scollard et
al., 2006a; Ranque et al., 2007).
If sufficiently immunosuppressive, could STH re-infection clear or
reduce the severity of leprosy reactions? Trials have employed thera-
peutic STH infection for inflammatory conditions such as allergy, multi-
ple sclerosis, type 1 diabetes and Crohn's disease, however, typically not
within STH endemic contexts (Wammes et al., 2014). Various helminth
excretory secretory (ES) proteins or exosomes containing diverse cargo
including microRNAs are also under investigation for effects including:
functional mimicry of TGF-β, suppressive T cell signaling, inhibition of
integrin binding that blocks neutrophils, dendritic cell switch to Th2
pathways, macrophage activation inhibition, inhibition of antigen pre-
sentation by B cells, production of IL-10, reduction of IL-12, and reduc-
tion of IL1R1/ST2 transcripts (Coakley et al., 2016). Remarkably, some
of our STH−/reaction-positive patients later became STH+ within a
few months; however, reaction did not necessarily subside (data not
shown). It may be that once a reaction is triggered by immune reconsti-
tution, the complicated cascade of networked events cannot be easily
reversed. Since corticosteroids increase risk for potentially fatal dissem-
inated Ss hyperinfection, it is not clinically recommendable for reaction
patients in STH-endemic settings to be permitted to retain or become
re-infected with STH. The ideal scenario would be for STH and leprosy
co-infections to be cured without instigation of immunopathological
complications; however, the practical logistics to achieve this are cur-
rently unclear.
STH-mediated immune dysregulation, deworming and immune re-
constitution in regard to leprosy may bring insight in areas of host sus-
ceptibility (or augmentation thereof), transmission (extended
subclinical status), vaccines and immunodiagnostics. Disease
124 D.A. Hagge et al. / EBioMedicine 23 (2017) 119–124diagnostics often target immune biomarkers that mounting evidence
now indicates map directly into STH-influenced pathways, which can
result in false negative, skewed or muted test results (Salgame et al.,
2013; Coakley et al., 2016; Thomas et al., 2010). If durations for arousing
detectable immune reconstitution in M. leprae infections prove similar
to tuberculosis (2–3 months), contacts or suspect cases could be
dewormed at an initial screening, provided WASH (Water, Sanitation
and Hygiene) training and then asked to return for immunodiagnostics
or immunotherapy at 3 months coincidental with existing post-expo-
sure chemoprophylaxis treatment schedules for contacts (Elias et al.,
2008; Richardus & Oskam, 2015). Admittedly, it could be theorized
that some subclinical cases would develop clinical symptoms including
leprosy reaction during immune reconstitution. Nevertheless, this
would happen 1) earlier in disease than otherwise, 2) with scheduled
follow-up and supervision by a health staff. Both aspects could promote
earlier detection and reduced risk of disability development, amajor ob-
jective of global leprosy programs.
There were limitations in this study, several of which will be ad-
dressed in ongoing further investigations. Increasingly available qPCR
primers and rapid tests for additional STH species can improve compre-
hensive endemic screening. Although cause and effect between
deworming and leprosy reaction has not yet been demonstrated, a larg-
er cohort with standardized deworming, WASH training, longitudinal
sampling and immune biomarker monitoring will permit mapping of
expected changes during immune reconstitution specific to M. leprae,
as well as potentially identify associated risk factors.
This study provides opening evidence that STH are not only sig-
nificantly relevant to leprosy patients but also reaction occurrence.
Recognition of STH as a complicit accomplice to leprosy outcomes
has proverbially “opened a can of worms.” Yet, by unearthing this
factor, programs could also gain impetus and insight from the cur-
rent thrust behind neglected tropical disease (NTD) research and
elimination initiatives. Where chronic STH are engaged for elimina-
tion,M. leprae-affected skin and nerves may befall aroused immuno-
logical crossfire potentially leading to self-healing or pathology.
After STH elimination, future populations may better host natural
immunity necessary to resist M. leprae infection – possibly on par
with areas where leprosy has been successfully eradicated. Perhaps
by the time STH leprosy co-infection relationships are better defined
alongside other NTD complicities, answers to these questions and
better options for mitigating reaction and disability development
risks will be on the horizon.
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